BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24171187)

  • 1. Cutaneous mastocytosis as a rare differential diagnosis for unilateral chronic facial pain and erythema: a case report.
    Troeltzsch M; Berndt R; Woodlock T; Messlinger K; Troeltzsch M
    J Orofac Pain; 2013; 27(4):367-71. PubMed ID: 24171187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of telangiectasia macularis eruptiva perstans with montelukast.
    Cengizlier R; Hücümenoğlu S; Ozen A; Tülin Sayli R
    Allergol Immunopathol (Madr); 2009; 37(6):334-6. PubMed ID: 19913347
    [No Abstract]   [Full Text] [Related]  

  • 3. Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.
    Kowalzic L; Eickenscheidt L; Seidel C; Kribus S; Ziegler H; Komar M
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):360-2. PubMed ID: 19054427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder.
    Martin LK; Romanelli P; Ahn YS; Kirsner RS
    Int J Dermatol; 2004 Dec; 43(12):922-4. PubMed ID: 15569020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telangiectasia macularis eruptiva perstans: an old terminology, still frequently used.
    Wilmas K; Wohlmuth-Wieser I; Duvic M
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral telangiectasia macularis eruptiva perstans with an unusual clinical presentation.
    Jia QN; Fang K; Qu T
    J Dermatol; 2018 Jul; 45(7):e201-e202. PubMed ID: 29424045
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant juvenile xanthogranuloma and cutaneous mastocytosis in a 3-year-old Swedish girl: case report and review of the literature.
    Gruber R; Vassilaki I; Zelger B
    Int J Dermatol; 2011 May; 50(5):611-4. PubMed ID: 21349079
    [No Abstract]   [Full Text] [Related]  

  • 8. Unilateral telangiectasia macularis eruptiva perstans of the breast.
    Patel N; Stranahan D; Fenske NA
    Cutis; 2012 Jul; 90(1):26-8. PubMed ID: 22908729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous mastocytosis: a review focusing on the pediatric population.
    Briley LD; Phillips CM
    Clin Pediatr (Phila); 2008 Oct; 47(8):757-61. PubMed ID: 18502981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ringed telangiectasias: an unusual presentation of telangiectasia macularis eruptiva perstans.
    Siddique L; Ahrns H; Seiverling E
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29196283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEP or not TMEP: That is the question.
    Marrouche N; Grattan C
    J Am Acad Dermatol; 2014 Mar; 70(3):581-2. PubMed ID: 24528906
    [No Abstract]   [Full Text] [Related]  

  • 12. Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma.
    Pascual JC; Bañuls J; Albares MP; Vergara G; Belinchón I; Silvestre JF; Betlloch I
    J Cutan Med Surg; 2003; 7(5):399-402. PubMed ID: 14973646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases.
    Tumer G; Jow T; McElligott S; Schwartz RA; Lambert WC
    Skinmed; 2017; 15(3):171-174. PubMed ID: 28705275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
    Michelerio A; Grassi S; Elena C; Croci GA; Boveri E; Bossi G; Brazzelli V
    Eur J Dermatol; 2019 Apr; 29(2):174-178. PubMed ID: 30973331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoxanthomatous or xanthelasmoid mastocytosis: Reporting a rare entity.
    Sinha P; Sandhu S; Sen A; Sood A
    Indian J Dermatol Venereol Leprol; 2020; 86(4):382-385. PubMed ID: 30785120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telangiectatic mastocytosis versus telangiectasia macularis eruptiva perstans.
    Urbina F
    J Dermatol; 2019 Mar; 46(3):e96-e97. PubMed ID: 30144139
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermpath & Clinic: Telangiectasia macularis eruptiva perstans.
    Castaño-Fernandez JL; Rodriguez-Cuadrado FJ; Sanchez-Gutierrez I; Najera-Botello L; Salguero Fernandez I; Roustan Gullon G; Rosell-Diaz AM
    Eur J Dermatol; 2022 Jul; 32(4):556-558. PubMed ID: 36301773
    [No Abstract]   [Full Text] [Related]  

  • 18. Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):46-7. PubMed ID: 20070840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telangiectasia macularis eruptiva perstans.
    Altiner A; Tzu J; Patel R; Meehan S; Sanchez M
    Dermatol Online J; 2011 Oct; 17(10):7. PubMed ID: 22031633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.